FDA, DOJ File Complaint Against Arkansas Compounder Following GMP Deviations

Drug Industry Daily
Following FDA inspections and a warning letter, the Department of Justice filed a civil complaint against the outsourcing facility Cantrell Drug Company, of Little Rock, Arkansas seeking a preliminary injunction to halt manufacturing and order the company to recall and destroy all drugs compounded, held or distributed.

To View This Article:


Subscribe To Drug Industry Daily